Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
insulin glargine (toujeo) (2 trials)
ubiquinone (1 trial)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Trials (3 total)
Trial APIs (2 total)